Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

payer survey

- PMLiVE

Gilead promotes Andrew Dickinson to CFO, increased M&A expected

Dickinson helmed company’s acquisition of Kite and partnership with Galapagos

Eli Lilly HQ

Lilly’s pegilodecakin fails in long-shot pancreatic cancer trial

Company still hopes drug can show promise in other cancer types

- PMLiVE

Alexion eyes Soliris combo with $930m deal to buy Achillion

Additional shares will be tied to various milestones

- PMLiVE

The Golden Goose

Why it’s so hard for the US to curb runaway drug prices

What is changing in cardiovascular disease care?

Paul Midgley, of Wilmington Healthcare, explores the NHS Long-term Plan’s strategy for tackling cardiovascular disease and what it means for pharma

Wilmington Healthcare

- PMLiVE

Litigation concerns threaten to overshadow solid quarter at J&J

Reports better-than-expected financial results

Roche Basel Switzerland

Roche reports continued growth in Q3, despite biosimilar competition

Spark acquisition expected to complete this year

- PMLiVE

Eli Lilly shutters UK neuroscience unit, with 80 job losses expected

Company says decision is not related to Brexit

Breaking the cookie cutter

Differentiated strategies need differentiated thinking

PANS PANDAS interview

PANDAS/PANS Awareness: A parent’s story

To help raise awareness of these often underdiagnosed diseases, Jon Hallows, Joint MD at Porterhouse shares his own experience as a parent of a son recently diagnosed with PANDAS

Porterhouse Medical Group

- PMLiVE

Leading AstraZeneca’s return to growth in Europe

PME talks to Iskra Reic, the company’s head of Europe and Canada

- PMLiVE

The era of digital wellbeing

Social media - friend or foe?

Page & Page Health

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links